Skip to main content
Premium Trial:

Request an Annual Quote

MorphoSys Inks Deal with Pfizer for Use of Slonomics Platform; Ups 2010 Guidance


German pharmaceutical company MorphoSys this week announced an agreement between its recently acquired subsidiary Sloning BioTechnology and Pfizer for the use of Sloning's Slonomics platform for the creation of gene and protein libraries.

The technology will be installed at Pfizer's subsidiary Rinat Neuroscience in South San Francisco. Per the arrangement, Morphosys will receive an upfront payment of an undisclosed amount this year, with the possibility of annual license fees over the patent lifetime of the Slonomics platform.

The Slonomics technology uses a library of double-stranded DNA triplets to construct protein libraries comprising defined mixtures of amino acids at predetermined positions. MorphoSys purchased Sloning in October to optimize production of its therapeutic and diagnostic antibodies (GWDN 10/07/2010).

Also this week, MorphoSys increased its financial guidance for 2010, attributing the increase primarily to "the achievement of revenues from additional commercial activities, resulting from the acquisition of Sloning."

The company now expects 2010 revenues of between €91 million to €94 million ($120 million to $124 million), up from the previous guidance of €89 million to €90 million. It projected operating profits of €13 million to €16 million, up from €7 million to €9 million.

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.